232 related articles for article (PubMed ID: 31282857)
1. Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells.
Brian BF; Jolicoeur AS; Guerrero CR; Nunez MG; Sychev ZE; Hegre SA; Sætrom P; Habib N; Drake JM; Schwertfeger KL; Freedman TS
Elife; 2019 Jul; 8():. PubMed ID: 31282857
[TBL] [Abstract][Full Text] [Related]
2. LynA regulates an inflammation-sensitive signaling checkpoint in macrophages.
Freedman TS; Tan YX; Skrzypczynska KM; Manz BN; Sjaastad FV; Goodridge HS; Lowell CA; Weiss A
Elife; 2015 Oct; 4():. PubMed ID: 26517880
[TBL] [Abstract][Full Text] [Related]
3. Depletion of Csk preferentially reduces the protein level of LynA in a Cbl-dependent manner in cancer cells.
Kuga T; Yamane Y; Hayashi S; Taniguchi M; Yamaguchi N; Yamagishi N
Sci Rep; 2020 May; 10(1):7621. PubMed ID: 32376886
[TBL] [Abstract][Full Text] [Related]
4. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
[TBL] [Abstract][Full Text] [Related]
5. Cbl functions downstream of Src kinases in Fc gamma RI signaling in primary human macrophages.
Erdreich-Epstein A; Liu M; Kant AM; Izadi KD; Nolta JA; Durden DL
J Leukoc Biol; 1999 Apr; 65(4):523-34. PubMed ID: 10204582
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of Lyn protein-tyrosine kinase by c-Cbl ubiquitin-protein ligase in Fc epsilon RI-mediated mast cell activation.
Kyo S; Sada K; Qu X; Maeno K; Miah SM; Kawauchi-Kamata K; Yamamura H
Genes Cells; 2003 Oct; 8(10):825-36. PubMed ID: 14531861
[TBL] [Abstract][Full Text] [Related]
7. Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells.
Gustin SE; Thien CB; Langdon WY
J Immunol; 2006 Nov; 177(9):5980-9. PubMed ID: 17056522
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
Masson K; Heiss E; Band H; Rönnstrand L
Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
[TBL] [Abstract][Full Text] [Related]
9. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.
Mukhopadhyay C; Triplett A; Bargar T; Heckman C; Wagner KU; Naramura M
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8228-E8237. PubMed ID: 27930322
[TBL] [Abstract][Full Text] [Related]
10. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
[TBL] [Abstract][Full Text] [Related]
11. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway.
Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R
J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467
[TBL] [Abstract][Full Text] [Related]
12. CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1.
Belizaire R; Koochaki SHJ; Udeshi ND; Vedder A; Sun L; Svinkina T; Hartigan C; McConkey M; Kovalcik V; Bizuayehu A; Stanclift C; Schenone M; Carr SA; Padron E; Ebert BL
Blood; 2021 Apr; 137(16):2209-2220. PubMed ID: 33512474
[TBL] [Abstract][Full Text] [Related]
13. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
14. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.
Goyama S; Schibler J; Gasilina A; Shrestha M; Lin S; Link KA; Chen J; Whitman SP; Bloomfield CD; Nicolet D; Assi SA; Ptasinska A; Heidenreich O; Bonifer C; Kitamura T; Nassar NN; Mulloy JC
Leukemia; 2016 Mar; 30(3):728-39. PubMed ID: 26449661
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells.
Ota Y; Beitz LO; Scharenberg AM; Donovan JA; Kinet JP; Samelson LE
J Exp Med; 1996 Nov; 184(5):1713-23. PubMed ID: 8920860
[TBL] [Abstract][Full Text] [Related]
17. A beta 1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration.
Meng F; Lowell CA
EMBO J; 1998 Aug; 17(15):4391-403. PubMed ID: 9687507
[TBL] [Abstract][Full Text] [Related]
18. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
19. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
[TBL] [Abstract][Full Text] [Related]
20. The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.
Shivanna S; Harrold I; Shashar M; Meyer R; Kiang C; Francis J; Zhao Q; Feng H; Edelman ER; Rahimi N; Chitalia VC
J Biol Chem; 2015 May; 290(20):12537-46. PubMed ID: 25784557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
